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Abstract Genital warts are a common and highly contagious sexually transmitted
disease. They have a large economic burden and affect several aspects of quality of
life. Incidence data underestimate the real occurrence of genital warts because this
infection is often under-reported, mostly due to their specific characteristics such as
the asymptomatic course. Genital warts cases for the analysis were obtained from the
catalan public health system database (SIDIAP) for the period 2009-2016, covering
74% of the Catalan population. People under 15 and over 94 years old were excluded
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from the analysis as the incidence of genital warts in this population is negligible.
This work introduces a time series model based on a mixture of two distributions,
capable of detecting the presence of under-reporting in the data. In order to identify
potential differences in the magnitude of the under-reporting issue depending on sex
and age, these covariateswere included in the model. This work shows that only about
80% in average of genital warts incidence in Catalunya in the period 2009-2016 was
registered, although the frequency of under-reporting has been decreasing over the
study period. It can also be seen that the under-reported issue has a deeper impact
on women over 30 years old. The registered incidence in the Catalan public health
system is underestimating the real burden in almost 10,000 cases in Catalunya, around
23% of the registered cases. The total annual cost in Catalunya is underestimated in at
least about 10 million Euros respect the 54 million Euros annually devoted to genital
warts in Catalunya, representing 0.4% of the total budget of the public health system.
Keywords genital warts · estimation · HPV · under-reporting · time series
1 Introduction
Health information systems are essential to ensure the safety and quality of health
care and improve adherence to clinical practice guidelines, but they are also a very
powerful tool concerning resources management and control, decision making, and
effective and efficient planning of prevention and control interventions[1,2]. How-
ever, the incompleteness and inaccuracy of the information is common in this type of
registries and can lead to problems at a clinical level, but also at a population level
such as the underestimation of some diseases. In Catalunya (Spain), the Information
System for Research in Primary Care (SIDIAP) was launched in 2010 with the inte-
gration of data from the clinical work station of primary care (ECAP) of the Catalan
Health Institute (ICS), which started in 1998, and other complementary sources[3].
The ICS is the main provider of health services in Catalunya and manages 283 out
of 370 Primary Care Teams with a catchment of 5,564,292 people, approximately
74% of the Catalan population1. Nevertheless, it is reasonable to assume that the in-
cidence of genital warts (GW) will be very similar among the Catalan population not
covered by ICS. In the particular case of sexually transmitted diseases, it is even more
important to have reliable information due to their remarkable morbidity, and there-
fore, the importance of controlling trends over time and priority setting (see [4] for a
comprehensive discussion focused on developing countries). GW are a common and
highly contagious sexually transmitted disease in Catalunya (in 2016 the incidence
was about 107 cases per 100,000 women and 139 cases per 100,000 men[5]) caused
by a subset of HPV types, with the most common being genotypes 6 and 11. They
are usually benign, or non-cancerous, skin growths that develop on the genital area.
However, they have an important negative impact on the health service and the in-
dividual, in addition to have a large economic burden and affect several aspects of
quality of life[6,7,8]. It is well known that incidence data underestimate, to some
1 http://ics.gencat.cat/es/lics/
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degree, the real occurrence of genital warts because this infection is often under-
reported, mostly due to their specific characteristics such as the asymptomatic course
of the disease[9]. Further, the SIDIAP database only includes data from the public
healthcare sector and around 28% of the general population in Catalunya have a dou-
ble health insurance coverage, public and private[10], so this fact can also explain
why GW incidence rates are underestimated, although this source of under-reporting
cannot be detected by the proposedmodel as we only have data from the public health
system. There has been a growing interest in the past recent years to deal with data
that are only partially registered or under-reported in the biomedical literature[11,12,
13,14,15,16]. Most of these previous works deal with discrete-valued time series,
whereas this paper is focused on the incidence of a disease, which should be treated
as a continuous-valued time series. Therefore, the aim of this work is to quantify the
under-reporting of genital warts cases in Catalunya and the reconstruction of the ac-
tual incidence in the period 2009-2016 on the basis of the mixture model described
in Section 2.
2 Methods
2.1 Population and incidence estimation
The study population included all residents in Catalunya assigned to an ICS primary
care center (74% of the Catalan population). Monthly GW incident cases for the
analysis were obtained from the SIDIAP database for the period 2009-2016.Episodes
of GW were classified as incident if they were preceded by at least 12-month period
without any episode. People under 15 and over 94 years old were excluded from the
analysis as the incidence of GW in this population is negligible (averages of 0.24
cases and 0.22 x 100,000 individuals over the period of study respectively).
2.2 Model
Consider Xt the series of real GW incidence, where t = 1,2, . . . is the time, following
a normal distribution with mean µ and variance σ2. In our setting, this process cannot
be directly observed, and all we can see is a part of it, expressed as
Yt =
{
Xt with probability 1−ωt
q ·Xt with probability ωt
(1)
The series Yt represents the registered values corresponding to GW incidence in
the part of Catalunya covered by ICS. According to Eq. 1, the registered observations
seriesYt is a mixture of two normally distributed random variablesYt = (1−ωt) ·Y1t +
wt ·Y2t , where Y1t coincides with the unobserved process and Y2t is a normal random
variable with mean µ and variance σ2. The parameter ωt is modeled as log(ωt) =
α0+α1 ·t and can be interpreted as the frequency of under-reporting at a time t, while
q can be interpreted as the intensity of such under-reporting, taking a value between
0 and 1. When q = 0 the observed incidence is Yt = 0 and when q = 1 there is no
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under-reporting. A value of ωt equal to 0 indicates that the observed value at time t is
not under-reported, and a value of ωt equal to 1 means that under-reporting is for sure
happening. In order to detect potential differences in GW incidence depending on sex
(men and women) and age (16-29 and 30-94), these covariates were included in the
model, so the mean of the observed processY1t was modeled as µ1t = β0+β1 · t +β2 ·
a+β3 · s+β4 ·a∗ s (where a is the age, s is the sex and a∗ s is the interaction between
age and sex). Similarly, the average of the second component can be recovered as
µ2t = q · (β0+β1 · t +β2 ·a+β3 · s+β4 ·a ∗ s). After fitting the previous model and
performing residuals examination, a seasonal behavior with period 3 months was
observed. Hence the model was updated by including the following trigonometric
function to reflect this periodic behavior:
f (t) = β5 · sin
(
2 ·pi · t
3
)
+β6 · cos
(
2 ·pi · t
3
)
,
on the terms µ1t and µ2t .
Other similar models were considered and the best fitting one, according to the
validation process described in Section 2.3, was chosen. In particular, as coefficients
β1 and β6 are not significant, models without linear trend and with only one peri-
odicity term were considered but the resulting validations were not satisfactory. The
estimates and their associated standard errors were obtained by maximizing the like-
lihood function using the nlm procedure in R[17]. The R package mixtools[18] was
used to obtain proper initial values for the maximization algorithm. All the data and
code used are available as supplementary material. If the main focus is not on quanti-
fying the under-reporting issue, an alternative approach to analyze these data might be
a hierarchical generalized linear model with random effects[19], implemented in the
R package HGLMM[20]. By means of this methodology the most likely unobserved
real GW incidence process is reconstructed using the components of the estimated
mixture, provided by the output of the mixtools procedure.
2.3 Validation
The model has been validated by analyzing its residuals. Figure 1 shows that they
behave like white noise as expected and that there are no significant auto-correlations
that should be accounted for. The residuals rt have been estimated as
rˆt =Yt −
(
ωˆt · qˆ ·
(
βˆ0+ βˆ1 · t + βˆ2 ·a+ βˆ3 · s+ βˆ4 ·a ∗ s
)
+(1− ωˆt) ·
(
βˆ0+ βˆ1 · t + βˆ2 ·a+ βˆ3 · s+ βˆ4 ·a ∗ s
))
where Yt is the total observed GW incidence at time t, and the letters with hat
indicate the estimated parameters.
3 Results
Our analysis estimates that, globally, only around 80% of actual GW incidence was
registered in the SIDIAP database in the period 2009-2016. For women over 30 years
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Fig. 1 Auto-correlations and partial auto-correlations of the model residuals.
Table 1 Registered and estimated GWmonthly average incidence (number of cases x 100,000 individuals)
in the period 2009-2016.
Sex Age Incidence (registered) Incidence (estimated) Difference (%)
Females
15-29 19.0 23.0 21.0%
30-94 3.9 4.9 24.9%
Average 6.8 8.4 23.2%
Males
15-29 18.4 20.8 13.3%
30-94 5.9 7.1 21.8%
Average 8.3 9.8 18.3%
Global 7.6 9.1 19.9%
old, the monthly average registered incidence is 3.9 cases per 100,000 women, while
the estimated monthly incidence is 4.9 cases per 100,000 women, 24.9% higher. On
males over 30 years old, the registered series has a monthly average of 5.9 cases
per 100,000 men for 7.1 cases per 100,000 men on the reconstructed series, 21.8%
higher. Regarding males under 30 years old, the reconstructed series is 13.3% higher
(monthly averages of 18.4 and 20.8 cases per 100,000 men for the registered and
reconstructed processes respectively). For women under 30 years old, the monthly
average registered incidence of GW in Catalunya is 19.0 per 100,000 women, while
the reconstructed hidden process has an average of 23.0 cases per 100,000 women,
about 21.0% larger. This information is summarized in Table 1 and described in more
detail in the supplementary material (Table S1).
Table 2 shows the estimated effect of the age and sex over the under-reporting
issue. In particular, it can be seen that the GW incidence is higher among younger
populations and men. It can also be noticed that a significant interaction between sex
and age group is found, which can be interpreted as a distinguishable impact of sex
on GW incidence depending on the age group.
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Table 2 Parameter estimates.
Covariate Parameter Estimate (95% CI)
α0 2.99 (1.77, 4.20)
t α1 -4.31 (-6.53, -2.09)
β0 13.76 (7.11, 20.40)
t β1 0.36 (-12.75, 13.46)
Age β2 -13.53 (-14.13, -12.92)
Sex β3 -1.60 (-2.24, -0.95)
Age∗Sex β4 3.25 (2.44, 4.06)
β5 4.16 (0.44, 7.88)
β6 0.52 (-5.59, 6.64)
q 0.75 (0.72, 0.77)
Figure 2 shows the registered (solid black line) and reconstructed unobserved
(dashed red line) processes for each of the considered sub-populations. Although this
figure shows increasing trends for all series, they are not well explained by coeffi-
cient β1, which is not significantly different from zero. Increasing trends are mainly
explained by the significant coefficient α1, which leads to a decreasing frequency of
under-reporting ωt .
Fig. 2 Registered (solid black line) and estimated underlying series (dashed red line) for each of the
considered sub-populations.
The under-reporting frequency is about 95% in 2009 (ω1) and around 21% in
2016 (ωt). This is measured by parameter α1 in Eq 1, and should not be confused
to overall under-reporting of the data, as its intensity (measured by parameter q in
the model) also plays a crucial role. For instance, all observations in a certain period
of time could be slightly under-reported (ω = 1, q near to 1), resulting in small dif-
ferences between registered and estimated values or just a few observations might
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Table 3 Registered, estimated and projected number of GW cases in Catalunya.
Sex Age SIDIAP
(registered)
SIDIAP
(estimated)
Catalunya
(registered projection)
Catalunya
(estimated projection)
Females
15-29 8051 9769 10280 12460
30-94 7625 9520 9062 11337
Total 15676 19289 19342 23797
Males
15-29 7967 9097 10166 11584
30-94 10774 13842 12914 16598
Total 18741 22939 23080 28182
Global 34417 42228 42422 51979
be under-reported (ω near to zero) but with a high intensity (q near to zero), poten-
tially resulting on large differences between registered and estimated values. Table 3
shows the total number of GW cases registered in the SIDIAP in the period of study,
the reconstructed values according to these registered cases and the projection over
the whole Catalan population, assuming that the incidence on the area outside ICS
coverage is the same.
4 Discussion
The results of this work show that in relative terms, the under-reporting issue has a
deeper impact on people over 30 years old (where GW incidence is lower), especially
among women. Nonetheless, the relative difference between registered and estimated
annual averages range between 13.3% and 24.9%. It is also remarkable that the qual-
ity of SIDIAP register regarding GW in Catalunya has been significantly improving
during the study period, as the frequency of under-reported observations has been de-
creasing over time. Facing under-reported information from public health registers is
very common in many situations, especially regarding potentially asymptomatic dis-
eases like GW. The proposed methodology considers the potential under-reporting in
continuous time series data in a very flexible way, estimating its frequency and inten-
sity, and it is general enough to be appropriate in a wide range of real situations in the
public health context. Additionally, the most likely non-observed process can be re-
constructed on the basis of estimated posterior probabilities. Moreover, the GW data
show that these models can deal with time-dependent under-reporting parameters,
seasonal behavior, trends and also incorporate the effect of other factors by including
covariates. The described methodology opens a wide field for future research lines.
In particular, if temporal correlations are found in the data, an appropriate model
should take this structure into account. One of the potential limitations of this study
is that the database used included data from the public healthcare setting and not from
the private sector. In Catalunya, it is estimated that 33% of women and 25% of men
aged 15 to 44 years have a double health insurance coverage (i.e. the public health
insurance and a private insurance plan)[10], so the rates estimated in our study are
likely still underestimating the real incidence of GW. One of its strengths is that the
same methodology (possibly with minor model modifications) could be used to ana-
lyze the frequency and intensity of potential under-reporting issues for any condition
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or setting in the absence of temporal dependence among the observations. The GW
incidence registered in SIDIAP is underestimating the real burden in almost 10,000
cases in Catalunya, around 23% of the registered cases. The annual per person cost of
GW was around 1000 Euros[8], so the potential total annual cost is underestimated
in at least about 10 million Euros respect the 54 million Euros devoted to GW in
Catalunya annually, representing 0.4% of the total budget of the Catalan Government
intended for health2, although about 2.8 million Euros would correspond to private
insurances. It is, therefore, clear that knowing the true burden of GW at the general
population level is important for health policy makers, especially after the introduc-
tion of prophylactic vaccines against HPV in many countries, as it plays a crucial role
in developing and evaluating prevention strategies[21,22].
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